Showing 20 of 10257 recruiting trials
Effects of Powerball in Children With Down Syndrome
Inhaled Molgramostim in Pediatric Participants With Autoimmune Pulmonary Alveolar Proteinosis (aPAP).
👨⚕️ Matthias Griese, MD,, Ludwig Maximilians Universität München📍 1 site📅 Started Oct 2025View details ↗
Test-retest Study With [18F]FBB in Cardiac Amyloidosis
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
👨⚕️ Hong Ha Rosa Nguyen, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Oct 2025View details ↗
Pivotal Study of the Velocity™ pAVF System
RecruitingNCT07487350 ↗
Recurrent Visceral Leishmaniasis in HIV Co-Infection
A Study of Efgartigimod IV in Participants From 12 Years to Less Than 18 Years of Age With Chronic Immune Thrombocytopenia (ITP)
RecruitingNCT07345949 ↗
Panniculitis in Dermatomyositis
The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
👨⚕️ Kevin Curran, MD, Memorial Sloan Kettering Cancer Center📍 3 sites📅 Started Oct 2025View details ↗
Multimodality Cardiac Imaging for Disease Progression in ATTR-CM
KD Treatment for Super-refractory Status Epilepticus
A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 02(BTC&HCC)]
Interleukin-6 Guided Treatment With Dexamethasone or Tocilizumab in Patients Hospitalized With Acute Respiratory Symptoms - a Feasibility Study
A Study to Evaluate the Safety and Efficacy of JNT-517 in Participants With Phenylketonuria (PKU)
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)
RecruitingNCT07354568 ↗
Prognosis of Patients With Mixed Cardiogenic-Vasoplegic Shock
Extended Prone Positioning for Intubated ARDS
👨⚕️ Thaïs Walter, Dr, University Hospital Saint-Louis Lariboisière, APHP📍 1 site📅 Started Oct 2025View details ↗
Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA
👨⚕️ STEFANO DEL GIACCO, MD, AZIENDA OSPEDALIERA UNIVERSITARIA CAGLIARI📍 1 site📅 Started Oct 2025View details ↗
RecruitingNCT07134777 ↗
Mechanisms of Visual Restoration After Occipital Stroke
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →